Effect of growth-promoting 17beta-estradiol, 19-nortestosterone and dexamethasone on circulating levels of nine potential biomarker candidates in veal calves.

G. Cacciatore, S.W. Eisenberg, C. Situ, M.H. Mooney, P. Delahaut, S. Klarenbeek, A.C. Huet, A.A. Bergwerff, C.T. Elliott

    Research output: Contribution to journalArticleAcademicpeer-review

    Abstract

    The use of screening methods based on the detection of biological effects of growth promoters is a promising approach to assist residue monitoring. To reveal useful effects on protein metabolism, male and female veal calves at 10 weeks of age were treated thrice with a combination of 25mg 17beta-estradiol 3-benzoate and 150 mg 19-nortestosterone decanoate with 2 weeks intervals and finally once with 4 mg dexamethasone. Hormone-treated calves showed a significant accelerated growth rate over 6 weeks. Plasma samples of treated and control calves were analysed for immunoreactive inhibin (ir-inhibin), osteocalcin, insulin-like growth factor 1 (IGF-1), insulin-like growth factor-binding protein 2 (IGFBP-2), IGFBP-3, luteinzing hormone (LH), follicle-stimulating hormone (FSH) and prolactin using immunoaffinity assays. Hormone treatment did not affect levels of IGF-1, IGFBP-2, IGFBP-3, LH, FSH and prolactin. The concentration of circulating ir-inhibin decreased, however, significantly (P
    Original languageUndefined/Unknown
    Pages (from-to)351-359
    Number of pages9
    JournalAnalytica Chimica Acta
    Volume637
    Issue number1-2
    Publication statusPublished - 2009

    Cite this